These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24603953)

  • 1. Health-related quality of life in Danish patients with hereditary angioedema.
    Aabom A; Andersen KE; Perez-Fernández E; Caballero T; Bygum A
    Acta Derm Venereol; 2015 Feb; 95(2):225-6. PubMed ID: 24603953
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in hereditary angioedema self-administration treatment: summary of an International Hereditary Angioedema Expert Meeting.
    Craig TJ
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():1-2. PubMed ID: 23689237
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in hereditary angioedema self-administration treatment: summary of an International Hereditary Angioedema Expert Meeting.
    Craig TJ
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():26-7. PubMed ID: 23689242
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary angioedema: children should be considered for training in self-administration.
    Abdel-Karim O; Dizdarevic A; Bygum A
    Pediatr Dermatol; 2014; 31(6):e132-5. PubMed ID: 25208595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of subcutaneous-C1 INH for acute therapy and prophylaxis of a child with HAE.
    Giardino F; Cicardi M; Neri S
    Pediatr Allergy Immunol; 2015 May; 26(3):296-297. PubMed ID: 25704296
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical approach to self-administration of intravenous C1-INH concentrate: a nursing perspective.
    Symons C; Rossi O; Magerl M; Andritschke K
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():17-20. PubMed ID: 23689240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary angioedema - consequences of a new treatment paradigm in Denmark.
    Bygum A
    Acta Derm Venereol; 2014 Jul; 94(4):436-41. PubMed ID: 24202369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency.
    Bork K
    Expert Rev Clin Immunol; 2011 Nov; 7(6):723-33. PubMed ID: 22014012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration.
    Cicardi M; Craig TJ; Martinez-Saguer I; Hébert J; Longhurst HJ
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():3-9. PubMed ID: 23689238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.
    Bygum A; Andersen KE; Mikkelsen CS
    Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant C1 esterase inhibitor (Ruconest) for hereditary angioedema.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):e44-5. PubMed ID: 27027690
    [No Abstract]   [Full Text] [Related]  

  • 12. Hereditary angioedema with normal C1 inhibitor.
    Patel NN; Patel DN
    Am J Med; 2008 Nov; 121(11):949-51. PubMed ID: 18954838
    [No Abstract]   [Full Text] [Related]  

  • 13. Hereditary angioedema: an update.
    Nigam PK
    Indian J Dermatol Venereol Leprol; 2011; 77(5):621-4. PubMed ID: 21860172
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of C1-inhibitor concentrate self-administration.
    Boysen HB; Bouillet L; Aygören-Pürsün E
    Int Arch Allergy Immunol; 2013; 161 Suppl 1():21-5. PubMed ID: 23689241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency.
    Vincent D; Ponard D; Fiorella S; Drouet C
    Ann Allergy Asthma Immunol; 2015 Jan; 114(1):68-70. PubMed ID: 25457864
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of ecallantide to treat a hereditary angioedema attack after failure of C1 inhibitor prophylaxis.
    Burke S; Petrov A; Johnson J; MacGinnitie A
    Ann Allergy Asthma Immunol; 2011 Aug; 107(2):181-2. PubMed ID: 21802029
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency.
    Bygum A; Fagerberg CR; Ponard D; Monnier N; Lunardi J; Drouet C
    Allergy; 2011 Jan; 66(1):76-84. PubMed ID: 20804470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients perception of self-administrated medication in the treatment of hereditary angioedema.
    Wang A; Fouche A; Craig TJ
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):120-5. PubMed ID: 26118352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biological response to rituximab treatment in 3 patients with acquired C1-inhibitor deficiency.
    Busse PJ; Gernez Y
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):380-382. PubMed ID: 28866304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.